India Oxytetracycline Market to be Dominated by Respiratory Infection Segment During the Forecast Period
Increase in number of infections
is expected to drive the growth of India oxytetracycline market during the
forecast period.
According
to TechSci Research report,“India Oxytetracycline Market By Type (Pharmaceutical
Grade, Veterinary Grade), By Route of administration (Oral, Intravenous,
Topical), By Source (In-house v/s Contract Manufacturing Organizations), By
Form (Tablet, Capsule, Injection, Ointment, Syrup), By Distribution Channel
(Online v/s Offline), By Application (Urinary Tract Infection, Respiratory
Infection, Skin, Eye and Ear Infections and Others), By Company, By Region,
Forecast & Opportunities, FY2026”, the India oxytetracycline market is expected to grow at a
steady rate during the forecast period. Oxytetracycline is a broad-spectrum
antibiotic which is known to be effective against wide range of infections. Rising
urinary tract infections caused by Escherichia coli and Pseudomonas aeruginosa,
is resulting in high demand for oxytetracycline, due to which the market is
expected to rev up in the next 5 years. Also,
it is also used to treat spirochetal infections, clostridial wound infection
and anthrax in patients that are sensitive to penicillin. This tends to create
growth opportunities for oxytetracycline market over the forecast period.
Growing investments in research and development activities by major market
players is expected to drive the market growth in the forthcoming years.
However, side effects of consuming oxytetracycline drug such as gastrointestinal
and photosensitive allergic reactions can restrict the market growth over the
next few years. Increased resistance to this antibiotic by some strains of
bacteria, has decreased its effectiveness for treating some types of infections,
which might act as major impediment to the market growth through FY2026.
Browse XX market data Tables and XX Figures spread
through XXX Pages and an in-depth TOC on " India Oxytetracycline
Market"
https://www.techsciresearch.com/report/india-oxytetracycline-market/7229.html
The India oxytetracycline market is segmented based on type, route of
administration, source, form, distribution channel, application, company, and
region. Based on application, the market can be fragmented into urinary tract
infection, respiratory infection, skin, eye and ear infections and others. The respiratory
infection segment is expected to dominate the market in the coming years on
account of increasing prevalence of pneumonia, whooping cough and other lower
respiratory tract infections in the country. Based on route of administration,
the market can be segmented into oral, intravenous, topical. The intravenous
route of administration is expected to register high growth in the coming years
on account of certain advantages it offers such as the response is very rapid,
and the dosage of the drug can be easily controlled. Furthermore, intravenous
route of administration is much useful in situations of poor gastrointestinal
absorption, which is further forecasted to contribute to the growth of segment.
Alpa Laboratories Ltd., Jagsonpal Pharmaceuticals Ltd., Cadila
Pharmaceuticals Ltd., Gracure Pharmaceuticals Ltd., Unicure India Pvt. Ltd.,
Pfizer Ltd. (Pharmacia India Pvt. Ltd.), Wockhardt Healthcare Ltd., Optho
Remedies Pvt. Ltd., Cyper Drugs & Pharmaceuticals Pvt. Ltd., Bini Laboratories
Pvt. Ltd and others are some of the leading players operating in India oxytetracycline
market. Companies operating in the market are using organic strategies such as
product launches, mergers and acquisitions and research collaborations to boost
their market share and to expand their geographic reach.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7229
Customers can also
request for 10% free customization on this report.
“India oxytetracycline market is expected
to witness steady growth during the forecast period on account of growing
adoption of oxytetracycline for treating infections such as chest infection
psittacosis, eye infection trachoma, genital infection urethritis and pneumonia.
Furthermore, new product developments by key market players is further expected
to fuel the market growth through FY2026. Besides, infections of skin and skin
structures is well treated by oxytetracycline which is expected to create lucrative
opportunities for the market growth over the next five years.”
said Mr. Karan Chechi, Research Director with TechSci Research, a research
based India management consulting firm.
“India Oxytetracycline Market By Type
(Pharmaceutical Grade, Veterinary Grade), By Route of administration (Oral,
Intravenous, Topical), By Source (In-house v/s Contract Manufacturing
Organizations), By Form (Tablet, Capsule, Injection, Ointment, Syrup), By
Distribution Channel (Online v/s Offline), By Application (Urinary Tract
Infection, Respiratory Infection, Skin, Eye and Ear Infections and Others), By
Company, By Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India oxytetracycline
market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with essential
drivers, challenges, and opportunities in India oxytetracycline market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]